First PI3K Inhibitor Approved for Metastatic, Advanced Breast Cancer

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

Piqray approved for HR-positive, HER2-negative, PIK3CA-mutated, metastatic or advanced breast cancer



You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.